Soligenix to receive $865,000 in non-dilutive funding through new jersey technology business tax certificate transfer program

Princeton, n.j., march 9, 2021 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has...
SNGX Ratings Summary
SNGX Quant Ranking